Medical School of Aristotle University of Thessaloniki
Thessaloniki, 54646, Greece
Location status: Recruiting
Location contact
Eleni Karlafti, Assistant Professor
CONTACT
Triantafyllos Didangelos, Professor MD PhD
CONTACT
NCT Number: NCT07839546
Observational study in physicians regarding their adherence to clinical guidelines (by American Diabetes Association 2025) for the management of type 2 diabetes mellitus and obesity via questionnaire
Interested in participating?
Request InfoAll sexes
Observational
Thessaloniki, 54646, Greece
Location status: Recruiting
Eleni Karlafti, Assistant Professor
CONTACT
Triantafyllos Didangelos, Professor MD PhD
CONTACT
Our study was an anonymous, questionnaire-based, cross-sectional study utilizing frequency-scale questions. The 2025 American Diabetes Association (ADA) 'Standards of Care in Diabetes' served as the guiding framework for this study, specifically Section 8, titled 'Obesity and Weight Management for the Prevention and Treatment of Type 2 Diabetes' . An online questionnaire was developed, consisting of questions that assessed the frequency of implementing the ADA guidelines, and was distributed to medical personnel nationwide for completion.
Healthy volunteers accepted: Yes
Only the study team can determine whether someone qualifies for participation.
Inclusion criteria
Exclusion criteria
A questionnaire titled "Physicians' adherence to the current clinical guidelines for the management of patients with type two diabetes mellitus and obesity" was formed, consisting of two sections and 18 closed-ended questions in total. Τhe first part focused on demographics and included four questions, while the second addressed the frequency of adherence to clinical guidelines and consisted of fourteen questions. A 5-point Likert scale, ranging from 'never', 'rarely' (1 - 2 times a month), 'sometimes' (1 - 2 times a week), 'frequently' (3 - 4 times a week) to 'always' (everyday), was used for the 14 questions, aiming to quantify the frequency of implementation. An introductory statement accompanied the questionnaire to provide study details and guarantee anonymous responses.
Time frame: From start of study (July 2025) until 1 year and half (October 2026)
A questionnaire titled "Physicians' adherence to the current clinical guidelines for the management of patients with type two diabetes mellitus and obesity" was formed, consisting of two sections and 18 closed-ended questions in total. Τhe first part focused on demographics and included four questions, while the second addressed the frequency of adherence to clinical guidelines and consisted of fourteen questions. A 5-point Likert scale, ranging from 'never', 'rarely' (1 - 2 times a month), 'sometimes' (1 - 2 times a week), 'frequently' (3 - 4 times a week) to 'always' (everyday), was used for the 14 questions, aiming to quantify the frequency of implementation. An introductory statement accompanied the questionnaire to provide study details and guarantee anonymous responses
Contact information is provided by the study sponsor or research team.
Eleni Karlafti, Assistant Professor MD PhD
CONTACT
Triantafyllos Didangelos Prof. MD PhD, Professor
CONTACT
Aristotle University Of Thessaloniki
Other
Adherence to Clinical Guidelines for the Management of Patients With Type Two Diabetes Mellitus and Obesity
OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.
View the official ClinicalTrials.gov record (opens in a new tab)This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.
Published trials that share one or more normalized conditions with this study.
NCT07144670
Adipose Tissue, Adipose Tissue Inflammation
Svendborg, Denmark
View Trial DetailsNCT07245082
Behavior, Body Weight
Taipei, Zhongzheng Dist, Taiwan
View Trial DetailsNCT07814508
Autoimmune Diseases, Continuous Glucose Monitoring System
Bad Mergentheim, Baden-Wurttemberg, Germany
View Trial DetailsNCT07812623
Diabetes Mellitus, Diabetes Mellitus Type 2
Eindhoven, North Brabant, Netherlands
View Trial Details